ScottsMiracle-Gro Sees Q1 EPS of $(1.20)-(1.25) vs $(1.13) Est

Symbols: SMG
Posted in: News, Guidance
Share

The Scotts Miracle-Gro Company (NYSE: SMG) today reiterated its outlook for fiscal 2012, although it expects results for its first quarter to be materially below the comparable period from fiscal 2011.

Sales for the period ending December 31 are expected to decline approximately $30 million from the same quarter a year ago. The adjusted net loss in the quarter is expected to range from $70 million to $75 million compared, or about $1.20 to $1.25 per share. That compares with a net loss of $65.6 million, or $0.99 per share, in fiscal 2011.


 
 
< Previous
Cyclacel Provides Update on Clinical Progress With Sapacitabine in Solid Tumors Including Activity in BRCA Mutation-Positive Patients
Next >
Galena Biopharma Presents 5 Year NeuVax Efficacy Data at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust